- Pharmaceutical giant GSK has announced plans to close its main research and development hub in Stevenage, Hertfordshire.
- GSK intends for its new 300,000 sq ft Cambridge centre to house over 1,000 scientists.
- This strategic move is part of a broader initiative to achieve £1.9 billion in cost savings over three years, with £400 million invested in facilitating these changes.
- Staff currently based in Stevenage will be moved to the company's upgraded Ware site, with GSK hoping all Stevenage workers will relocate to either Cambridge or Ware.
- The cost savings are earmarked to fund increased R&D efforts and help offset the financial impact when one of its key HIV treatments, dolutegravir, loses its patent protection.
IN FULL
